Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 040594
Company: MYLAN

Products on ANDA 040594

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
MERCAPTOPURINE	MERCAPTOPURINE	50MG	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 040594

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
07/01/2005	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
01/24/2022	SUPPL-13	Labeling-Package Insert		Label is not available on this site.
01/29/2021	SUPPL-12	Labeling-Package Insert		Label is not available on this site.
12/10/2018	SUPPL-10	Labeling-Package Insert		Label is not available on this site.
05/14/2013	SUPPL-6	Labeling-Container/Carton Labels		Label is not available on this site.

Therapeutic Equivalents for ANDA 040594

MERCAPTOPURINE

TABLET;ORAL; 50MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
MERCAPTOPURINE	MERCAPTOPURINE	50MG	TABLET;ORAL	Prescription	No	AB	040461	DR REDDYS LABS SA
MERCAPTOPURINE	MERCAPTOPURINE	50MG	TABLET;ORAL	Prescription	No	AB	040528	HIKMA
MERCAPTOPURINE	MERCAPTOPURINE	50MG	TABLET;ORAL	Prescription	No	AB	040594	MYLAN
PURINETHOL	MERCAPTOPURINE	50MG	TABLET;ORAL	Prescription	Yes	AB	009053	STASON PHARMS